| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |